CVNA holder files Form 144 to sell 32,370 shares on NYSE

Rhea-AI Filing Summary

CVNA: A holder filed a Form 144 notice to sell 32,370 shares of common stock, with an aggregate market value $9,765,407.50. The approximate sale date is 10/31/2025, through Morgan Stanley Smith Barney LLC, on the NYSE.

The shares to be sold include 13,190 acquired via an option exercise on 10/30/2025, plus multiple restricted stock vestings in 2024–2025 (e.g., 7,277 on 04/01/2024; 7,094 on 05/01/2024; 702 on 09/01/2025; 702 on 10/01/2025). Shares outstanding were listed as 141,423,193.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32370	9765407.50	141423193	10/31/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/30/2025	Exercise of options under a registered plan	Issuer			13190	10/30/2025	Compensation
Common	01/01/2024	Restricted stock vesting under a registered plan	Issuer			123	01/01/2024	Compensation
Common	08/01/2024	Restricted stock vesting under a registered plan	Issuer			552	08/01/2024	Compensation
Common	08/01/2025	Restricted stock vesting under a registered plan	Issuer			702	08/01/2025	Compensation
Common	10/01/2025	Restricted stock vesting under a registered plan	Issuer			702	10/01/2025	Compensation
Common	05/01/2024	Restricted stock vesting under a registered plan	Issuer			7094	05/01/2024	Compensation
Common	09/01/2024	Restricted stock vesting under a registered plan	Issuer			552	09/01/2024	Compensation
Common	02/01/2024	Restricted stock vesting under a registered plan	Issuer			122	02/01/2024	Compensation
Common	09/01/2025	Restricted stock vesting under a registered plan	Issuer			702	09/01/2025	Compensation
Common	04/01/2024	Restricted stock vesting under a registered plan	Issuer			7277	04/01/2024	Compensation
Common	07/01/2024	Restricted stock vesting under a registered plan	Issuer			552	07/01/2024	Compensation
Common	07/01/2025	Restricted stock vesting under a registered plan	Issuer			703	07/01/2025	Compensation
Common	03/01/2024	Restricted stock vesting under a registered plan	Issuer			99	03/01/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did CVNA’s Form 144 disclose?

A proposed sale of 32,370 common shares with an aggregate market value of $9,765,407.50.

When is the proposed sale date for CVNA shares?

The filing lists an approximate sale date of 10/31/2025.

Which broker will handle the CVNA share sale?

The notice names Morgan Stanley Smith Barney LLC as broker.

On which exchange are the CVNA shares to be sold?

The filing lists the NYSE.

How were the CVNA shares acquired by the seller?

Shares include 13,190 from an option exercise on 10/30/2025 and multiple restricted stock vestings across 2024–2025.

How many CVNA shares are outstanding?

The filing lists 141,423,193 shares outstanding.

Does the issuer receive proceeds from this Form 144 sale?

Form 144 covers sales for the seller’s account; it does not register new shares for the issuer.